MedTrace Logo

Vascular Fingerprint Validation Study

NCT02573584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2024-05-17

No results posted yet for this study

Summary

The vascular fingerprint is a simple selection tool to identify testicular cancer patients with a high risk of arterial cardiovascular events during and in the first year after cisplatin chemotherapy. Eventually, this selection method allows a relative small randomized intervention study with i.e. LMWH during chemotherapy to prove the effectiveness and safety in lowering the chance of an arterial cardiovascular event.

Conditions

  • Testicular Cancer

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Jourik A Gietema, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • Netherlands
  • Portugal
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02573584 on ClinicalTrials.gov